Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Diagnostics’ Asia Pacific Managing Director Roland Diggelmann On Delivering Personalized Medicine: An Interview With PharmAsia News (Part 2 of 2)

This article was originally published in PharmAsia News

Executive Summary

Roche Diagnostics, world leaders in in vitro diagnostics, has identified Asia Pacific as its fastest-growing region. Among other Asia-Pac countries is India, which has been consistently growing at 30 percent for the company. Roland Diggelmann, Managing Director at Roche Diagnostics Asia Pacific told PharmAsia News that with a slew of product launches the region will continue to play a bigger role in the global plans of the company. Diggelmann, who has several countries like Australia, China, Hong Kong, India, Indonesia, Korea, Malaysia, New Zealand, Pakistan, Philippines, Singapore, Taiwan, Thailand, and Vietnam under his charge, discusses Roche's plans in this interview.
Advertisement

Related Content

New Wave Of Cancer Drugs Puts Hard Focus On Need For Inexpensive Screening
New Wave Of Cancer Drugs Puts Hard Focus On Need For Inexpensive Screening
Roche Diagnostics’ Asia Pacific Managing Director Roland Diggelmann On Delivering Personalized Medicine: An Interview With PharmAsia News (Part 1 of 2)
Roche Diagnostics’ Asia Pacific Managing Director Roland Diggelmann On Delivering Personalized Medicine: An Interview With PharmAsia News (Part 1 of 2)
Advertisement
UsernamePublicRestriction

Register

SC070804

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel